A day after the World Health Organization (WHO) suspended trials to evaluate the efficacy of hydroxychloroquine (HCQ) for COVID-19 treatment, India said it will continue to use the medicine for prevention of the disease. The Indian Council of Medical Research (ICMR), the country's leading medical advisory body, has found that consuming the drug hydroxychloroquine reduces the chances of contracting COVID-19. ICMR released an advisory recommending usage of HCQ as a preventive medication for frontline workers against the novel coronavirus. ICMR, however, cautioned that the intake of the medicine should not instill a sense of false security.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
